Thus, we hypothesize that the anti-tumor role of cytotoxic Tr1 cells in this context is driven by the ability of PD1 blockade to preferentially enhance production of Th1 cytokines such as IFNγ over IL10 in Tr1-like CD4 T cells from human cancer samples (134). The gene discussed is CD4; the disease is neoplasm.